We are live on
!
Find out more
Axsome Therapeutics
AXSM
AXSM
257 hedge funds and large institutions have $3.28B invested in Axsome Therapeutics in 2024 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 78 increasing their positions, 97 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
22% more funds holding in top 10
Funds holding in top 10: 9 → 11 (+2)
10% more call options, than puts
Call options by funds: $50M | Put options by funds: $45.3M
6% more capital invested
Capital invested by funds: $3.09B → $3.28B (+$186M)
3.94% more ownership
Funds ownership: 81.84% → 85.79% (+3.9%)
0% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 33
1% less funds holding
Funds holding: 260 → 257 (-3)
20% less repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 97
Holders
257
Holders Change
-3
Holders Change %
-1.15%
% of All Funds
3.71%
Holding in Top 10
11
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+22.22%
% of All Funds
0.16%
New
33
Increased
78
Reduced
97
Closed
33
Calls
$50M
Puts
$45.3M
Net Calls
+$4.73M
Net Calls Change
+$21.6M
Top Buyers
Top Sellers
| 1 |
PA
Perceptive Advisors
New York
|
-$47.8M |
| 2 |
Morgan Stanley
New York
|
-$46M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$28.9M |
| 4 |
Pictet Asset Management
Carouge,
Switzerland
|
-$25.8M |
| 5 |
JFG
Jefferies Financial Group
New York
|
-$23.5M |
